Soft Matter 7, 83588362
Simultaneously, this includes, as described before [20,26,27,67], even with delayed therapy application, no thrombosis (or at least marked thrombosis attenuation) as a point of the eliminated/attenuated stasis as well as resolved Virchow triad situation [20,21,22,23,24,25,26,27]
However, BPC 157 remains experimental and is not FDA-approved for human medical use
Research community sources commonly describe rotating injection sites (abdomen, outer thigh, back of upper arm) to lower the chance of local irritation
If a patient starts Repatha and a GLP-1 within a few months of each other, it's incredibly easy to conflate the effects and mistakenly believe the weight loss is coming from the Repatha
Response times differ